Polar Asset Management Partners Inc. - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Polar Asset Management Partners Inc. ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$2,241,538
-7.1%
1,009,702
+42.3%
0.05%
+16.3%
Q2 2023$2,412,980
-14.8%
709,7000.0%0.04%0.0%
Q1 2023$2,831,703
-26.7%
709,7000.0%0.04%
-8.5%
Q4 2022$3,860,768
+8.1%
709,7000.0%0.05%
+9.3%
Q3 2022$3,570,000
+32.0%
709,7000.0%0.04%
+38.7%
Q2 2022$2,704,000
-55.9%
709,700
-18.2%
0.03%
-53.0%
Q1 2022$6,133,000867,5000.07%
Other shareholders
TRANSPHORM INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,609,346$14,401,2915.31%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$90,477,1602.72%
Worth Venture Partners, LLC 884,802$3,530,3601.72%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,084$1,009,8051.18%
Black Maple Capital Management LP 43,161$172,2120.16%
Polar Asset Management Partners Inc. 709,700$2,831,7030.04%
Soros Fund Management 639,820$2,552,8820.04%
AMERIPRISE FINANCIAL INC 3,929,048$15,676,9010.01%
Stratos Wealth Partners, LTD. 25,640$102,3040.00%
FMR LLC 1,584$6,3200.00%
View complete list of TRANSPHORM INC shareholders